678 related articles for article (PubMed ID: 51889)
1. Studies on the induction and expression of T cell-mediated immunity. IV. Non-overlapping populations of alloimmune cytotoxic lymphocytes with specificity for tumor-associated antigens and transplantation antigens.
Kedar E; Bonavida B
J Immunol; 1975 Nov; 115(5):1301-8. PubMed ID: 51889
[TBL] [Abstract][Full Text] [Related]
2. Antigenic specificity of the cytolytic T lymphocyte (CTL) response to murine sarcoma virus-induced tumors. I. Preferential reactivity of in vitro generated secondary CTL with syngeneic tumor cells.
Plata F; Jongeneel V; Cerottini JC; Brunner KT
Eur J Immunol; 1976 Nov; 6(11):823-9. PubMed ID: 187429
[TBL] [Abstract][Full Text] [Related]
3. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells.
Green WR
J Immunol; 1983 Dec; 131(6):3078-84. PubMed ID: 6605998
[TBL] [Abstract][Full Text] [Related]
4. Effect of graft-versus-host disease on anti-tumor immunity.
Schreiber KL; Forman J
J Immunol; 1990 Mar; 144(5):2018-26. PubMed ID: 1968493
[TBL] [Abstract][Full Text] [Related]
5. Minor H antigens introduced on H-2 different stimulating cells cross-react at the cytotoxic T cell level during in vivo priming.
Bevan MJ
J Immunol; 1976 Dec; 117(6):2233-8. PubMed ID: 825578
[TBL] [Abstract][Full Text] [Related]
6. Cell-mediated immune responses to syngeneic tumors. I. Identification of two distinct CTL effector pathways which differ in antigen specificity, genetic regulation, and cell surface phenotype.
Lynch DH; Daynes RA; Hodes RJ
J Immunol; 1986 Feb; 136(4):1521-7. PubMed ID: 2418117
[TBL] [Abstract][Full Text] [Related]
7. H-2 antigen-specific cytotoxic T cells induced by concanavalin A: estimation of their relative frequency.
Bevan MJ; Langman RE; Cohn M
Eur J Immunol; 1976 Mar; 6(3):150-6. PubMed ID: 62665
[TBL] [Abstract][Full Text] [Related]
8. CD3+ T cells in severe combined immunodeficiency (scid) mice. IV. Graft-vs.-host resistance of H-2d scid mice to intravenous injection of allogeneic H-2b (C57BL/6) spleen cells.
Claesson MH; Rudolphi A; Tscherning T; Reimann J
Eur J Immunol; 1991 Sep; 21(9):2057-62. PubMed ID: 1832384
[TBL] [Abstract][Full Text] [Related]
9. Alloimmune cytotoxic T cells: Evidence that they recognize serologically defined antigens and bear clonally restricted receptors.
Bevan MJ
J Immunol; 1975 Jan; 114(1 Pt 2):316-9. PubMed ID: 123256
[TBL] [Abstract][Full Text] [Related]
10. Continuously proliferating T killer cells specific for H-2b targets: selection and characterization.
Dennert G; De Rose M
J Immunol; 1976 Jun; 116(6):1601-6. PubMed ID: 58039
[TBL] [Abstract][Full Text] [Related]
11. Cell-mediated immunity to Friend virus-induced leukemia. III. Characteristics of secondary cell-mediated cytotoxic response.
Ting CC; Kirchner H; Rodrigues D; Park JY; Herberman RB
J Immunol; 1976 Jan; 116(1):244-52. PubMed ID: 54388
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of in vivo generation of cytotoxic effector cells against tumor in tumor-bearing mice.
Fuyama S; Yamamoto H; Fujii Y; Arai S
Cancer Res; 1986 Nov; 46(11):5548-52. PubMed ID: 2428480
[TBL] [Abstract][Full Text] [Related]
13. The importance of serologically detectable histocompatibility antigens in the induction and effector step of cell-mediated lysis.
Dennert G; Hyman R
Eur J Immunol; 1977 May; 7(5):251-7. PubMed ID: 141372
[TBL] [Abstract][Full Text] [Related]
14. Studies on the induction and expression of T cell-mediated immunity. XIV. Antigen-nonspecific oxidation-dependent cellular cytotoxicity (ODCC) mediated by sodium periodate oxidation of cytotoxic T lymphocytes.
Fan J; Bonavida B
J Immunol; 1983 Sep; 131(3):1426-32. PubMed ID: 6193189
[TBL] [Abstract][Full Text] [Related]
15. T lymphocyte responses to multiple minor histocompatibility antigens generate both self-major histocompatibility complex-restricted and cross-reactive cytotoxic T lymphocytes.
Tremblay N; Fontaine P; Perreault C
Transplantation; 1994 Jul; 58(1):59-67. PubMed ID: 8036709
[TBL] [Abstract][Full Text] [Related]
16. Induction and characterization of minor histocompatibility antigens. Specific primary cytotoxic T lymphocyte responses in vitro.
Ando K; Nakashima I; Nagase F; Isobe K; Kawashima K; Hasegawa Y; Yoshida T; Iwamoto T; Hasegawa T; Muro Y
J Immunol; 1988 Feb; 140(3):723-9. PubMed ID: 2448374
[TBL] [Abstract][Full Text] [Related]
17. Studies on the induction and expression of T cell-mediated immunity. 3. Amplification by papain of the generation of cytotoxic lymphocytes to allogeneic cells.
Kedar E; Bonavida B
J Immunol; 1974 Oct; 113(4):1386-9. PubMed ID: 4153487
[No Abstract] [Full Text] [Related]
18. In vitro induction of tumor-specific immunity. III. Lack of requirement for H-2 compatibility in lysis of tumor targets by T cells activated in vitro to oncofetal and plasmacytoma antigens.
Burton RC; Chism SE; Warner NL
J Immunol; 1977 Mar; 118(3):971-80. PubMed ID: 300394
[TBL] [Abstract][Full Text] [Related]
19. Characterization of alloimmunization-induced T lymphocytes reactive against AKR leukemia in vitro and correlation with graft-vs-leukemia activity in vivo.
Truitt RL; Shih CY; Lefever AV; Tempelis LD; Andreani M; Bortin MM
J Immunol; 1983 Oct; 131(4):2050-8. PubMed ID: 6194224
[TBL] [Abstract][Full Text] [Related]
20. Augmentation of syngeneic tumor-specific immunity by semiallogeneic cell hybrids.
Toffaletti DL; Darrow TL; Scott DW
J Immunol; 1983 Jun; 130(6):2982-6. PubMed ID: 6189910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
